We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Illustration

FDA Authorizes First Nanopore Sequencing-Based Test for SARS-CoV-2

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to the Clear Dx SARS-CoV-2 novel descriptive diagnostic from Clear Labs (San Carlos, CA, USA), making it the first nanopore sequencing-based test for SARS-CoV-2 to receive EUA. More...
25 Sep 2020
Illustration

New ABC Test for Influenza A, Influenza B, and COVID-19 to Be Launched in First Week of October

A new ABC Test (Influenza A/Influenza B/COVID-19) is anticipated to be ready for launch to US CLIA laboratory customers the first week of October 2020. More...
25 Sep 2020
Illustration

FDA Authorizes First Point-of-Care Antibody COVID-19 Test

The US Food and Drug Administration (FDA Silver Spring, MD, USA) has issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19. More...
25 Sep 2020
Illustration

Routine Blood Test Predicts Increased Mortality Risk in COVID-19 Patients

A standard test that assesses blood cells can identify which patients who are admitted to the hospital with COVID-19 face a high risk of becoming critically ill and dying. More...
24 Sep 2020
Image: Researchers at Karolinska Institutet have developed methods that completely circumvent the RNA-extraction procedure (Photo courtesy of Karolinska Institutet)

New Test Developed with Simplified Buffer Formations Enables Fast, Cheap and Accurate COVID-19 Diagnosis

A new method developed for fast, cheap, yet accurate testing for COVID-19 infection simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics and making it particularly attractive for places and situations with limited resources, for repeated testing and for moving resources from expensive diagnostics to other parts of the care chain. More...
24 Sep 2020
Illustration

Four-in-One Test Kit for Detecting Influenza A, Influenza B, RSV and SARS-CoV-2 Set to Launch in November

A new four-in-one test kit for detecting influenza A, influenza B, RSV and SARS-CoV-2 is set to be launched in the coming month of November before the flu season begins in the Northern hemisphere. More...
24 Sep 2020
Image: New COVID-19 Antibody Assay Can Analyze Up to 40,000 Samples per Day Using Serum or Dried Blood (Photo courtesy of Neoteryx LLC)

New COVID-19 Antibody Assay Can Analyze Up to 40,000 Samples per Day Using Serum or Dried Blood

A new COVID-19 antibody assay can analyze up to 40,000 samples per day and is suitable for both serum and dried blood sampling. More...
24 Sep 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.